Filing Details
- Accession Number:
- 0001491519-20-000003
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-03-03 14:59:24
- Reporting Period:
- 2020-03-02
- Accepted Time:
- 2020-03-03 14:59:24
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 896747 | American Bio Medica Corp | ABMC | Pharmaceutical Preparations (2834) | 141702188 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1491519 | Chaim Davis | C/O Abmc 122 Smith Road Kinderhook NY 12106 | Yes | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares | Acquisiton | 2020-03-02 | 528,571 | $0.07 | 2,978,486 | No | 4 | P | Indirect | By Revach Fund, LP |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | By Revach Fund, LP |
Footnotes
- These restricted common shares were issued on 3/2/20 in connection with a private placement dated 2/20/20. The Revach Fund, LP was one of the accredited investors who participated in the private placement. 528,571 units were purchased at $0.07 per share; resulting in a total purchase price of $37,000. Davis is a managing member of Revach Group, LLC which operates as the general partner for Revach Fund, LP. Davis serves as the Chairman of the Board of American Bio Medica Corporation.
- The price per unit in the private placement was $0.07.
- The common shares are in the name of Revach Fund, LP. The reporting person (Davis) is a managing member of Revach Group, LLC which operates as the general partner for Revach Fund, LP.
Billionaire Hedge Funds
